ÂÜÀòÂÒÂ×

Dr. Gadi has 30 years of experience in cancer research and expertise in clinical care, clinical oncology, and translational breast cancer research. He is a pioneer in the use of patient-derived organoids for both drug target discovery and functional drug screening for patient care. His research interests include breast cancer, immunogenetics and immunotherapy for solid tumors, and the development of cell-based therapies for cancer.

VK is Director of Medical Oncology, and Associate Director of Translational Medicine at the University of Illinois Cancer Center at Chicago. Before joining U.I.C., he was an Associate Member of the Fred Hutchinson Cancer Research Center Clinical Research and Public Health Sciences Divisions and an Associate Professor at the University of Washington, Division of Oncology. He is a board-certified medical oncologist with a sub-specialty in breast cancer. He is a serial biotech innovator, has co-founded several companies, and sits on the scientific board of both nascent and mature biotech companies.

He received his M.D. and Ph.D. in Physiology and Biophysics at the University of Alabama at Birmingham. He completed his internal medicine residency at the University of Washington and his oncology fellowship at Fred Hutchinson Cancer Research Center in Seattle, Washington. Dr. Gadi also holds a B.S. in Biology/Biological Sciences from the University of Alabama at Birmingham.